Physician profile
Daniel R Whiting
NPI 1356637995
$39,308.44
in general payments reported to CMS, 2019-2025
12 companies · $18K in 2025
The $18K reported for 2025 was more than what 91% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,411 · 2020: $102 · 2021: $744 · 2022: $6,253 · 2023: $1,120 · 2024: $10K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Travel and Lodging: $3,570 · Food and Beverage: $2,979.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,250.00 |
| Travel and Lodging | $3,569.67 |
| Food and Beverage | $2,979.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Development Corporation | $29,150.05 | 2019-2025 | |
| Naviswiss, INC. | $8,969.85 | 2023-2024 | Naviswiss Knee System, Naviswiss Hip/Knee Systems, Naviswiss Knee Navigation |
| Restor3d, INC. | $451.61 | 2025 | |
| Medacta USA, INC. | $215.80 | 2023-2024 | Gmk Sphere |
| Onkos Surgical, INC. | $99.30 | 2025 | Eleos Limb Salvage System |
| Innovation Technologies INC | $99.30 | 2023 | Irrisept |
| Avanos Medical | $83.25 | 2021 | |
| Think Surgical, INC. | $67.37 | 2023 | |
| Orthalign INC | $65.39 | 2024 | Orthalign Plus |
| Heron Therapeutics, INC. | $63.60 | 2022 | |
| Stryker Corporation | $31.00 | 2019 | |
| Pacira Therapeutics, INC. | $11.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Whiting listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.